Embla Medical hf. (CPH:EMBLA)
28.15
+0.05 (0.18%)
Nov 16, 2026, 2:31 PM CET
Embla Medical Revenue
Embla Medical had revenue of $249.58M USD in the quarter ending September 30, 2026, with 5.40% growth. This brings the company's total for the last twelve months to $997.24M, up 11.20% year-over-year. In the year 2025, Embla Medical had annual revenue of $928.69M with 8.63% growth. That makes Embla Medical the 7,784th largest company in the world by revenue and 38th in Denmark.
Revenue (ttm)
$997.24M
Revenue Growth
+11.20%
P/S Ratio
1.82
Revenue / Employee
$221.61K
Employees
4,500
Market Cap
11.97B DKK
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Embla Medical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 928.69M | 73.80M | 8.63% |
| Dec 31, 2024 | 854.89M | 69.21M | 8.81% |
| Dec 31, 2023 | 785.68M | 67.03M | 9.33% |
| Dec 31, 2022 | 718.65M | -19.00K | - |
| Dec 31, 2021 | 718.67M | 89.17M | 14.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Novo Nordisk | 333.65B |
| Coloplast | 28.94B |
| Genmab | 28.27B |
| Demant | 24.63B |
| GN Store Nord | 16.52B |
| ALK-Abelló | 6.83B |
| Ambu A/S | 6.47B |
| Bavarian Nordic | 6.34B |
Embla Medical News
- 27 days ago - Embla Medical Earnings Call Transcript: Q3 2026 - Transcripts
- 27 days ago - Embla Medical Quarterly report: Q3 2026 - Filings
- 27 days ago - Embla Medical Slides: Q3 2026 - Filings
- 27 days ago - Embla Medical Earnings Call Transcript: Q3 2026 - Transcripts
- 27 days ago - Embla Medical Quarterly report: Q3 2026 - Filings
- 27 days ago - Embla Medical Slides: Q3 2026 - Filings
- 2 months ago - Embla Medical Slides: Investor presentation - Filings
- 2 months ago - ÖSSUR RENEWS PARTNERSHIP WITH HUNTER WOODHALL THROUGH 2028 - PRNewsWire